SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
16 references·1 citing·35 second hop
R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry (1995)R&D Costs, Innovative Output and Firm Siz…Market Structure and Technological Change (2013)Market Structure and Technolo…Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Scale, Scope, and Spillovers:…Success rates for new drugs entering clinical testing in the United States (1995)Success rates for new drugs e…Research and Development Costs for New Drugs by Therapeutic Category (1995)Research and Development Cost…Returns to R&D on new drug introductions in the 1980s (1994)Returns to R&D on new drug in…Do Important Drugs Reach the Market Sooner? (1994)Do Important Drugs Reach the …Pricing, Profits, and Technological Progress in the Pharmaceutical Industry (1993)Pricing, Profits, and Technol…Innovative productivity and returns to scale in the pharmaceutical industry (1993)Innovative productivity and r…Investment and Research and Development at the Firm Level: Does the Source of Financing Matter? (1992)Investment and Research and D…Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Brand Loyalty, Entry, and Pri…The Handbook of Industrial Organization (1991)The Handbook of Industrial Or…Cost of innovation in the pharmaceutical industry (1991)Cost of innovation in the pha…A New Look at the Returns and Risks to Pharmaceutical R&D (1990)A New Look at the Returns and…Innovation and Growth: Schumpeterian Perspectives (1986)Innovation and Growth: Schump…"Innovation in the Pharmaceutical Industry". (1978)"Innovation in the Pharmaceut…Research and Technical Change in the Pharmaceutical Industry (1965)Research and Technical Change…The impact of ESG on firm value: The moderating role of cash holdings (2025)The impact of ESG on firm val…Medical Care Costs: How Much Welfare Loss? (1992)Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs (1999)Review of the literature on reference pricing (2000)Generic entry, price competition, and market segmentation in the prescription drug market (2007)Economic and Political Weekly (2017)Industrial Market Structure and Economic Performance. (1971)Product differentiation advantages of pioneering brands (1980)Generic Entry and the Pricing of Pharmaceuticals (1997)Uncertainty and Learning in Pharmaceutical Demand (2005)Killer Acquisitions (2020)Capitalism, Socialism and Democracy. (1943)Limited-dependent and qualitative variables in econometrics (1983)Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research (2001)Scale effects of R&D as reflected in earnings and returns (2011)The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry (2011)Conditional logit analysis of qualitative choice behavior (1972)Qualitative Response Models: A Survey (1994)Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals (2003)The cost of biopharmaceutical R&D: is biotech different? (2007)Essential medicines for universal health coverage (2016)Firm Size and R&D Intensity: A Re-Examination (1987)Spatial Clustering, Local Accumulation of Knowledge and Firm Competitiveness (1996)Stylized Facts in the Geography of Innovation (2010)The Dynamic Role of Small Firms: Evidence from the U.S. (2002)Competition and innovation behaviour (2005)The Anatomy of Industry R&D Intensity Distributions (2016)Innovation and Technological Change (2003)The Institutional Structure of Production (2005)Estimating Market Power and Strategies (2007)The nature of innovation market failure and the design of public support for private innovation (2000)Entrepreneurship, Frictions, and Wealth (2006)R&D investments in family and founder firms: An agency perspective (2010)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)The Burden of Knowledge and the “Death of the Renaissance Man”: Is Innovation Getting Harder? (2008)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)
this work references cited by second hop

References

  • 1996Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery1,389 cited
  • 1991Cost of innovation in the pharmaceutical industry763 cited
  • 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
  • 1986Innovation and Growth: Schumpeterian Perspectives457 cited
  • 1992Investment and Research and Development at the Firm Level: Does the Source of Financing Matter?416 cited
  • 2013Market Structure and Technological Change320 cited
  • 1990A New Look at the Returns and Risks to Pharmaceutical R&D286 cited
  • 1993Innovative productivity and returns to scale in the pharmaceutical industry258 cited
  • 1993Pricing, Profits, and Technological Progress in the Pharmaceutical Industry255 cited
  • 1991The Handbook of Industrial Organization223 cited
  • 1994Returns to R&D on new drug introductions in the 1980s197 cited
  • 1978"Innovation in the Pharmaceutical Industry".194 cited
  • 1995Success rates for new drugs entering clinical testing in the United States184 cited
  • 1995Research and Development Costs for New Drugs by Therapeutic Category169 cited
  • 1994Do Important Drugs Reach the Market Sooner?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

143 cited
  • 1965Research and Technical Change in the Pharmaceutical Industry138 cited
  • Cited by

    • 2025The impact of ESG on firm value: The moderating role of cash holdings31 cited